Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

NCT02800486 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Anaplastic Astrocytoma
Anaplastic Oligoastrocytoma
Glioma
Brain Neoplasm
Brain Cancer
Brain Tumor
Brain Tumor, Recurrent
Brain Neoplasm, Malignant

Interventions

DRUG: Intra-arterial Cetuximab
DRUG: Intra-arterial Mannitol
RADIATION: Hypofractionated re-irradiation

Sponsor

Northwell Health